Grinstead Eric 4
4 · SYNAGEVA BIOPHARMA CORP · Filed Jun 29, 2012
Insider Transaction Report
Form 4
Grinstead Eric
SVP, Commercial Operations
Transactions
- Award
Stock Option (Right to Buy)
2012-06-27+43,000→ 43,000 totalExercise: $40.74Exp: 2022-06-27→ Common Stock (43,000 underlying)
Footnotes (1)
- [F1]25% of the total number of shares subject to the option vest and become exercisable on June 27, 2013 and 1/36 of the remainder of the shares subject to the option shall vest and become exercisable monthly thereafter.